Rising Disease Prevalence Spurs Growth In Direct-To-Consumer Genetic Testing Market: A Significant Driver Propelling The Direct-To-Consumer (DTC) Genetic Testing Market In 2025

The Direct-To-Consumer (DTC) Genetic Testing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Expected Direct-To-Consumer (DTC) Genetic Testing Market Size During the Forecast Period?
Recently, there has been significant growth in the size of the direct-to-consumer (DTC) genetic testing market. It is expected to rise from $1.84 billion in 2024, achieving a size of $2.14 billion in 2025. This is an estimated compound annual growth rate (CAGR) of 16.2%. The expansion during the historic era is linked to an increased interest in ancestry and heritage, health and wellness trends, effective marketing and consumer education, control, and privacy over one's genetic data, as well as affordability and accessibility of these tests.

Anticipated to experience substantial growth in the forthcoming years, the direct-to-consumer (DTC) genetic testing market is projected to escalate to a value of $3.9 billion in 2029, with a compound annual growth rate (CAGR) of 16.2%. Factors fueling this growth during the forecast period include the augmenting range of test offerings, fusion with personalized medicine, alliances with health and well-being sectors, progress in genetic research, as well as governmental backing and regulation. Significant trends during the forecast period encompass the enhancement of test offerings and panels, consumer-awareness initiatives, regulatory adherence and supervision, genomic data studies and contributions, cost reductions, and augmented accessibility.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8957

What Are the High-Growth Segments in the Direct-To-Consumer (DTC) Genetic Testing Market?
The direct-to-consumer (DTC) genetic testing market covered in this report is segmented -

1) By Type: Carrier Testing, Predictive Testing, Ancestry And Relationship Testing, Nutrigenomic Testing, Other Types
2) By Sample: Saliva, Urine, Blood
3) By Technology: Single Nucleotide Polymorphism Chips, Whole Genome Sequencing, Targeted Analysis
4) By Business Model: Health Planning Model, Comprehensive Genome Tests Model, Medical Precision Tests Model, Restricted Trait Tests Mode
5) By End User: Laboratories, Blood Banks, Nursing Homes, Hospitals, Imaging Centers, Home Care, Cosmetics, Other End-User

Subsegments:
1) By Carrier Testing: Autosomal Recessive Disorders, X-Linked Disorders
2) By Predictive Testing: Risk Assessment For Genetic Conditions, Adult-Onset Conditions
3) By Ancestry And Relationship Testing: Ancestry Composition Analysis, DNA Matching For Relationships
4) By Nutrigenomic Testing: Dietary Recommendations, Metabolism And Fitness Insights
5) By Other Types: Pharmacogenomic Testing, Health Trait Testing

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8957&type=smp

What Key Drivers Are Expected to Influence Future Direct-To-Consumer (DTC) Genetic Testing Market Growth?
The increase in diseases and conditions capable of genetic transmission is anticipated to fuel the expansion of the direct-to-consumer (DTC) genetic testing market. A genetic disorder, brought about by DNA mutations, can cover single-gene, multifactorial, and chromosomal disorders. Direct-to-consumer genetic testing heightens awareness of multiple genetic disorders, endorsing health predictions and supplying customized health, disease risk, and trait information. Consequently, this facilitates potent health and lifestyle choices to minimize disease risk. For instance, in April 2023, the US-based National Library of Medicine (NLM) disclosed that roughly 6.7 million Americans aged 65 and older would be afflicted with Alzheimer's dementia (AD) - in which genetics hold a critical role - in 2023. This count could reach 13.8 million by 2060, barring medical advancements capable of preventing, slowing, or curing AD. Thus, the escalating incidence of diseases and conditions capable of genetic transmission is largely responsible for the upward trajectory of the direct-to-consumer (DTC) genetic testing market.

Which Companies Hold the Largest Share Across Different Direct-To-Consumer (DTC) Genetic Testing Market Segments?
Major companies operating in the direct-to-consumer (DTC) genetic testing market include 23andMe, AncestryDNA, MyHeritage, FamilyTreeDNA, Living DNA, Vitagene, Orig3n, DNAfit, Helix, Color Genomics, Circle DNA, CRI Genetics, MapMyGenome, Invitae Corporation, TellmeGen, Pathway Genomics, Genebase Systems, EasyDNA, Nebula Genomics, Dante Labs, Veritas Genetics, Xcode Life, Genomic Express, Genomelink, Genomind, WellnessFX, LetsGetChecked, iGene, Dnadoc, OneOme

What Are the Latest Developing Trends in the Direct-To-Consumer (DTC) Genetic Testing Market?
Prominent businesses in the direct-to-consumer (DTC) genetic testing market are emphasizing on genetic research investments to maintain their market standing. Such investments give genetic testing companies the required financial support for research and development, technological advancements, market expansion, regulatory compliance, and fostering innovation. For instance, Redcliffe Labs, a diagnostic and diagnosis lab based in India, unveiled its plan to invest an extra $10 million (approximately Rs 81 crore) in expanding its genetic and specialized testing suite in November 2022. This investment is expected to further boost the firm's genetic testing abilities in prenatal, oncology, neurology, nephrology, and pharmacogenomics sectors. The company has already put $6 million into genetic and specialized testing enhancements and is concentrating on emerging technologies in the diagnostic field.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/direct-to-consumer-dtc-genetic-testing-global-market-report

What Are the Emerging Geographies for The Direct-To-Consumer (DTC) Genetic Testing Market Growth?
North America was the largest region in the direct-to-consumer (DTC) genetic testing market share in 2024. Asia-Pacific was the second-largest region in the global direct-to-consumer (DTC) genetic testing market. The regions covered in the direct-to-consumer (dtc) genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Direct-To-Consumer (DTC) Genetic Testing Market?
2. What is the CAGR expected in the Direct-To-Consumer (DTC) Genetic Testing Market?
3. What Are the Key Innovations Transforming the Direct-To-Consumer (DTC) Genetic Testing Industry?
4. Which Region Is Leading the Direct-To-Consumer (DTC) Genetic Testing Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.